MediPal Holdings Corporation
MAHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -16.63 | 0.09 | -0.43 | 0.63 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 1,617.73 | 13.36 | 16.32 | 12.19 |
| Quality | ||||
| ROIC | 0.01% | 1.17% | 0.73% | 1.49% |
| Gross Margin | 6.53% | 6.84% | 7.12% | 6.90% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -6.77% | 2.84% | 3.00% | 2.90% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -1,581.60 | -14.13 | -17.62 | -10.97 |
| Interest Coverage | 3,676.49 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.03 | 4.85 | 4.51 | 4.20 |
| Cash Conversion Cycle | -727.17 | -3.75 | 1.89 | -6.71 |